FDA Approves Nayzilam (midazolam) Nasal Spray to Treat Seizure Clusters

FDA Approves Nayzilam (midazolam) Nasal Spray to Treat Seizure Clusters Print this page Brussels (Belgium) & Atlanta, Georgia (U.S.) – May 20 2019: UCB announced today that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application for the company’s newest anti-epileptic drug (AED) Nayzilam (midazolam) nasal spray CIV, a benzodiazepine indicated… Read More »

National Hepatitis Testing Day 2019

May is hepatitis awareness month, and Sunday, May 19, marks National Hepatitis Testing Day 2019. It’s a chance to remind the public and health care providers alike that everyone should be tested for viral hepatitis. What’s viral hepatitis? There are three main types: Hepatitis A virus (HAV), hepatitis B virus (HBV) and hepatitis C virus… Read More »

Bipolar disorder during pregnancy: Lessons learned

Careful management of bipolar disorder during pregnancy is critical because for so many patients with this illness, the road to emotional well-being has been a long one, requiring a combination of careful pharmacologic and nonpharmacologic strategies.Half of referrals to our Center for Women’s Mental Health – where we evaluate and treat women before, during, and… Read More »